FUTURE ONCOLOGY
Volume 5 #7 April 28, 2000
State-of-the-Art in the Management of Cancer
LUNG CANCER-PART IV
Non-small-cell Lung Cancer-Epidemiology,
Tumor Markers, Diagnosis, Staging and Prognosis
Epidemiology
Gender Variations in the Incidence of NSCLC
Age Factors in the Incidence of NSCLC
Stage at Diagnosis
Survival
NSCLC Incidence by Histologic
Type
Tumor
Markers
Hereditary Factors
Other Biomarkers
Diagnosis
and Screening
Noninvasive Imaging
Electron
beam tomography (EBT)
Positron
emission tomography (PET)
In vitro
Approaches
Cell-associated
transferrin receptor (TfR)
Cyfra
21-1
DR-70
Gastrin-releasing
protein receptor (GRPr)
Heterogeneous
nuclear ribonucleoprotein (hnRNP) A2/B1
Homeobox
genes
MAb
28K29
Microsatellite
alterations
Telomerase
Staging
Revisions in the International System for Staging Lung
Cancer
Noninvasive Imaging
CT
staging
FDG
PET imaging
MR
scanning
Surgical Staging
Mediastinotomy/mediastinoscopy
Thoracoscopy
and video-assisted thoracoscopy (VATS)
Intra-operative
sentinel lymph node mapping
Molecular Substaging
Prognosis
Serum Markers
Tissue Pathology
Angiogenesis
Genetic Tests
FDG PET
Imaging
|